SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-22-155181
Filing Date
2022-05-19
Accepted
2022-05-19 17:26:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 425 d324985d425.htm 425 84711
2 GRAPHIC g324985g03d05.jpg GRAPHIC 34057
  Complete submission text file 0001193125-22-155181.txt   127931
Mailing Address 280 PARK AVENUE, SUITE 43W NEW YORK NY 10017
Business Address 280 PARK AVENUE, SUITE 43W NEW YORK NY 10017 6466036716
Brookline Capital Acquisition Corp. (Filed by) CIK: 0001814140 (see all company filings)

IRS No.: 851260244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 280 PARK AVENUE, SUITE 43W NEW YORK NY 10017
Business Address 280 PARK AVENUE, SUITE 43W NEW YORK NY 10017 6466036716
Brookline Capital Acquisition Corp. (Subject) CIK: 0001814140 (see all company filings)

IRS No.: 851260244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-39488 | Film No.: 22944280
SIC: 2836 Biological Products, (No Diagnostic Substances)